Back
BioMarin Pharmaceutical, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$59.99
Seasonality Move:
-0.09%
7 Day Trial
ALL ACCESS PASS
$
7
BioMarin Pharmaceutical, Inc. Stock Forecast
-
Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 15.3% based on the past 26 years of stock performance.
-
BioMarin Pharmaceutical, Inc. has risen higher in 15 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.69%
-
Is BioMarin Pharmaceutical, Inc. Stock Undervalued?The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $60.32. The Score for BMRN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BioMarin Pharmaceutical, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 15.3% based on the past 26 years of stock performance.
BioMarin Pharmaceutical, Inc. Stock Rating
Sell
36
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
Is BioMarin Pharmaceutical, Inc. overpriced?
-
BioMarin Pharmaceutical, Inc. has risen higher in 15 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.69%
BioMarin Pharmaceutical, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
73.18
52-Week Low:
50.76
Prediction Charts
Market Cap:
11.6B
Price in USD:
60.32
Volume:
2.5M
Beta:
0.83
Technical Analysis
SMA50:
59.09
SMA100:
56.58
SMA200:
56.62
52-Wk Change:
-14.43%
Stock Predictions
-
Is BioMarin Pharmaceutical, Inc. stock public?Yes, BioMarin Pharmaceutical, Inc. is a publicly traded company.
-
What is the BioMarin Pharmaceutical, Inc. stock quote today?The BioMarin Pharmaceutical, Inc. stock price is 60.32 USD today.
-
How to buy BioMarin Pharmaceutical, Inc. stock online?You can buy BioMarin Pharmaceutical, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-20 | 63.09 | 64.08 | 64.25 | 62.55 |
| Feb-23 | 64.08 | 62.92 | 65.95 | 62.63 |
| Feb-24 | 60.30 | 62.62 | 66.28 | 59.63 |
| Feb-25 | 62.14 | 61.44 | 62.53 | 61.18 |
| Feb-26 | 61.36 | 61.11 | 61.44 | 59.56 |
| Feb-27 | 60.89 | 61.73 | 63.22 | 60.59 |
| Mar-2 | 60.71 | 59.74 | 61.14 | 59.25 |
| Mar-3 | 59.98 | 58.53 | 60.32 | 58.50 |
| Mar-4 | 59.00 | 60.43 | 61.19 | 58.50 |
| Mar-5 | 60.43 | 60.57 | 61.20 | 59.72 |
| Mar-6 | 60.23 | 61.12 | 61.52 | 59.16 |
| Mar-9 | 60.91 | 60.88 | 61.88 | 59.83 |
| Mar-10 | 60.85 | 60.89 | 61.97 | 60.60 |
| Mar-11 | 60.18 | 60.32 | 61.26 | 59.25 |
BioMarin Pharmaceutical, Inc. Earnings
BioMarin Pharmaceutical, Inc. Earnings Report: Per Share BioMarin Pharmaceutical, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioMarin Pharmaceutical, Inc. Forecast Revenue Growth
BioMarin Pharmaceutical, Inc. Stock Analysis: Historical quarterly revenues per share for BioMarin Pharmaceutical, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.07 per share, an increase next quarter of $0.08 per share, an increase this year of $2.08 per share, and an increase next year of $1.31 per share.
* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.